Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities

Model‐informed drug development (MIDD) approaches have rapidly advanced in drug development in recent years. Additionally, the Prescription Drug User Fee Act (PDUFA) VI has specific commitments to further enhance MIDD. Tumor growth dynamic (TGD) modeling, as one of the commonly utilized MIDD approac...

Descripción completa

Detalles Bibliográficos
Autores principales: Al‐Huniti, Nidal, Feng, Yan, Yu, Jingyu (Jerry), Lu, Zheng, Nagase, Mario, Zhou, Diansong, Sheng, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438808/
https://www.ncbi.nlm.nih.gov/pubmed/32589767
http://dx.doi.org/10.1002/psp4.12542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438808/
https://www.ncbi.nlm.nih.gov/pubmed/32589767
http://dx.doi.org/10.1002/psp4.12542

Ejemplares similares